ID   BEL-7402/5-FU
AC   CVCL_5493
SY   Bel7402/5-FU; BEL-7402/FU; Bel/5Fu
DR   ChEMBL-Cells; CHEMBL4482981
DR   ChEMBL-Targets; CHEMBL4483230
DR   PRIDE; PXD015917
DR   PubChem_Cell_line; CVCL_5493
DR   Wikidata; Q54795970
RX   PubMed=16696913;
RX   PubMed=23167424;
CC   Problematic cell line: Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 42.3 +- 3.3 hours (PubMed=23167424).
CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Deep quantitative proteome analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5492 ! BEL-7402
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 19
//
RX   PubMed=16696913; DOI=10.3736/jcim20060309;
RA   Gu W., Zhang Y.-N., Li B., Han J., Cheng B.-B., Ling C.-Q.;
RT   "Establishment of a multidrug-resistant cell line BEL-7402/5-FU of
RT   human hepatocellular carcinoma and its biological characteristics.";
RL   Zhong Xi Yi Jie He Xue Bao 4:265-270(2006).
//
RX   PubMed=23167424; DOI=10.7314/APJCP.2012.13.9.4807;
RA   Gu W., Fang F.-F., Li B., Cheng B.-B., Ling C.-Q.;
RT   "Characterization and resistance mechanisms of a
RT   5-fluorouracil-resistant hepatocellular carcinoma cell line.";
RL   Asian Pac. J. Cancer Prev. 13:4807-4814(2012).
//